Abstract: Disclosed are techniques for mitigating loss of information in electronically transmitted images caused by compression operations performed on the images to facilitate transmissions. When an image for electronic transmission is received, a computer vision model extracts various points of data from the image corresponding to information present in the image that is intended for human consumption (for example, in a scan of a handwritten note from a doctor prescribing a medicine for a patient, some of the data points may include the name of the medicine, the dosage value, and when the medicine should be consumed). A test transmission image is then generated by applying the compression operations which are applied in the electronic transmission to a copy of the image, and that copy is also inputted to the computer vision model for data point extraction. Differences in the extracted data points are used to modify the image for transmission.

Abstract: According to one embodiment, a method, computer system, and computer program product for smoothing one or more surfaces of a 3D-printed object in reduced gravity is provided. The present invention may include positioning one or more radiative heating elements to evenly heat one or more surfaces of a 3D-printed object based on a shape of the 3D-printed object; determining, for at least one of the one or more radiative heating elements, a desired heat output necessary to melt the outermost layers of the one or more surfaces; and pulsing the one or more radiative heating elements to melt the one or more surfaces, wherein the duration and frequency of the pulsing is configured to achieve the desired heat output.

Abstract: An optoacoustic probe for optoacoustic imaging of a volume is provided that includes a housing extending from a distal end operable to contact the volume to a proximal end. The optoacoustic probe includes a light source configured to generate light that is transmitted along a light pathway to generate return signals when the light reacts with the volume, and a transducer assembly including a transducer configured to receive the optoacoustic return signals and an acoustic lens provided over the transducer. The optoacoustic probe also includes a steering assembly coupled within the housing and configured to steer the light pathway to generate the light along the light pathway at different scanning areas of the volume based on the return signals.

Abstract: A laser assembly is provided that includes a laser pump chamber that emits a first light through a laser cavity at a first wavelength, and a polarization assembly that receives the first light and converts the first light into a pulsed light that includes the first light at the first wavelength and a first polarization. The laser assembly also includes a second light at the first wavelength and a second polarization.

Abstract: An embodiment of the invention may include a method, computer program product and computer system for the generation of synthetic images to enhance a diagnostic imaging order. The method, computer system, and computer program product may include receiving a verbal description of a clinical finding with respect to an anatomical part of a patient. The computing device may generate text from the received verbal description. The computing device may then identify a clinical finding in the text, the clinical finding describing a portion of an anatomical part of the patient at a particular location within the anatomical part. The computing device may also generate a synthetic image of the anatomical part including a mark indicating the portion at the particular location within the anatomical part of the clinical finding. Additionally, the computing device may be capable of generating a textual clinical order based on the received verbal description.

Abstract: Embodiments of the invention provide methods for predicting the onset of menarche, i.e. a females first menstrual period, through the measurement of salivary hormone levels (e.g. 17-? estradiol, testosterone, progesterone, and/or 17 hydroxy-progesterone (17-OHP)). In particular, the methods described herein enable a reliable determination that menarche will, or will not occur, within varied time intervals, e.g. 1 to 30 days, 1 to 45 days, 1 to 60 days and 1 to 90 days. Diagnostic kits and products of manufacture comprising the kits are also provided.